Yellow fever – Gabon
On 15 April 2020, WHO received information regarding a confirmed case of yellow fever in Magandi village, Tchibanga city in Nyanga Province of southern Gabon, 590 km from the capital, Libreville. The case is an 83-year-old male with no known vaccination history for yellow fever. He had onset of symptoms on 30 January 2020 and presented to a health facility on 2 February 2020 with abdominal pain and jaundice. Between 2 February and 9 April, he consulted the Urban Health Centre in Tchibanga, the Christian Alliance Hospital in Bongolo and the University hospital in the capital Libreville where the case received anti-malarial...
Source: WHO Disease Outbreaks - June 17, 2020 Category: Infectious Diseases Tags: news Source Type: news

Asian Tiger Mosquito Showing Up in Illinois
FRIDAY, June 12, 2020 -- The Asian tiger mosquito -- which can spread diseases such as chikungunya or dengue fever -- has become more common across Illinois in recent decades, a new study finds. This species of mosquito originated in the forests of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 12, 2020 Category: General Medicine Source Type: news

Asian tiger mosquito gains ground in Illinois
(University of Illinois at Urbana-Champaign, News Bureau) Researchers report that the Asian tiger mosquito, Aedes albopictus, has become more abundant across Illinois in the past three decades. Its spread is problematic, as the mosquito can transmit diseases -- like chikungunya or dengue fever -- to humans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

Bharat Bio Consortium Gets $14m Grant for Chikungunya Vaccine
In a statement, Bharat Bio said CEPI will fund the consortium for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 3, 2020 Category: Pharmaceuticals Source Type: news

CEPI awards up to $14.1 million to IVI and Bharat Biotech to advance development of Chikungunya vaccine
(International Vaccine Institute) CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of a Chikungunya vaccine. CEPI will provide the consortium with up to US $14.1 million for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 3, 2020 Category: Infectious Diseases Source Type: news

Emerging viral diseases causing serious issues in west Africa
(University of Colorado Anschutz Medical Campus) In a new study, researchers from the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus call attention to the emergence of mosquito-borne viral outbreaks in West Africa, such as dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2020 Category: International Medicine & Public Health Source Type: news

Methotrexate Treatment of Chronic Chikungunya Arthritis Methotrexate Treatment of Chronic Chikungunya Arthritis
Is methotrexate a safe and effective therapeutic option for chikungunya-related chronic arthritis? The authors report their experience with this treatment.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Rapid Response Toolbox
Source: Medical Mission Institute. Published: 2/2020. This toolbox, updated in February 2020, provides information and materials about rapid response to diseases and outbreaks, including situation reports about COVID-19 (coronavirus disease), plague, cholera, Marburg Virus, and Yellow Fever. It provide clinical guidelines, including for COVID-19,chikungunya, dengue, Ebola, and Zika; information about communication and training; and prevention and control information. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 1, 2020 Category: International Medicine & Public Health Source Type: news

A Zika vaccine could save suffering and costs
(CUNY Graduate School of Public Health and Health Policy) A new study led by researchers at the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the National School of Tropical Medicine at Baylor College of Medicine found that routinely giving the Zika vaccine to women of childbearing age could save money if the risk of Zika is around that of other mosquito-borne diseases like dengue and chikungunya. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 23, 2020 Category: Infectious Diseases Source Type: news

Skin cream used to treat GENITAL WARTS could protect people against diseases carried by mosquitoes
Scientists studied the effect of the cream, which is sold as Imiquimod or Aldara, on four types of virus transmitted by mosquitoes, including Zika and Chikungunya. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2020 Category: Consumer Health News Source Type: news

Mauritius: Inter-Sectoral Collaboration Is Key to Control and Prevent Outbreak of Vector-Borne Diseases
[Government of Mauritius] 'An inter-sectoral collaboration is key to control and prevent the outbreak of vector-borne diseases such as malaria, dengue and chikungunya, in particular during the currently prevailing cyclonic and rainy season'. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 16, 2020 Category: African Health Source Type: news

Sudan: 'Sudan Free of Dengue, Chikungunya' - Minister
[Radio Dabanga] Sudan -Sudan's Ministry of Health has declared that the country is free of dengue and Chikungunya for the first time since August 2019. The International Epidemiological Office of the World Organisation for Animal Health (OIE) has declared that livestock is also free of epidemic diseases in Sudan. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 6, 2020 Category: African Health Source Type: news

Sudan: Malaria Breached Epidemic Threshold in 2019
[Radio Dabanga] Khartoum -More than 1.8 million cases of malaria were reported from across Sudan so far in 2019, a sharp increase compared to previous years, the UN Office for the Coordination of Humanitarian Affairs (OCHA) reported on Thursday. Cases of diphtheria, dengue fever, rift valley fever, chikungunya, and cholera continue to be recorded across the country, according to the Sudanese Ministry of Health. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 16, 2019 Category: African Health Source Type: news

Mechanism that triggers the inflammatory process by Mayaro virus is discovered
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) A Brazilian team at FAPESP-supported Center for Research on Inflammatory Diseases identified the strategy used by immune cells to combat the pathogen Mayaro virus, which causes symptoms similar to those of chikungunya fever. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 2, 2019 Category: Infectious Diseases Source Type: news

Chikungunya Virus Disease: Annual Epidemiological Report for 2018; Surveillance Report
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 12/2019. This six-page report on cases of chikungunya virus disease is based on data for 2018 retrieved from The European Surveillance System (TESSy) on September 10, 2019. For 2018, 14 countries in the European Union/European Economic Area reported 160 cases of chikungunya virus disease, of which 113 (71 percent) were confirmed. All cases were travel-related. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - December 1, 2019 Category: International Medicine & Public Health Source Type: news